Modulators of arginine metabolism support cancer immunosurveillance

BMC Immunology

Volumn 10, Issue , 2009, Pages

  Capuano, Giusy ^a   Rigamonti, Nicolò ^a,b   Grioni, Matteo ^a   Freschi, Massimo ^a   Bellone, Matteo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; SILDENAFIL; ENZYME INHIBITOR; GAMMA INTERFERON; IMMUNOLOGIC FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER IMMUNOLOGY; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PROTEIN METABOLISM; SPLEEN CELL; SUPPRESSOR CELL; TUMOR IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; IMMUNOSURVEILLANCE; LYMPH NODE; METABOLISM; MYELOPOIESIS; NEOPLASM; PATHOLOGY; SPLEEN; TUMOR CELL LINE; WEIGHT REDUCTION;

ANIMALS; ARGININE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC SURVEILLANCE; INTERFERON-GAMMA; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID CELLS; MYELOPOIESIS; NEOPLASMS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; SPLEEN; WEIGHT LOSS;

EID: 61849136323     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-1     Document Type: Article

References (43)

1. Mellor AL Munn DH Creating immune privilege: Active local suppression that benefits friends, but protects foes Nat Rev Immunol 2008, 8:74-80 10.1038/nri2233 18064049
2. Rabinovich GA Gabrilovich D Sotomayor EM Immunosuppressive Strategies that are Mediated by Tumor Cells Annu Rev Immunol 2007, 25:267-96 10.1146/annurev.immunol.25.022106.141609 17134371
3. Sakaguchi S Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 2005, 6:345-52 10.1038/ni1178 15785760
4. Curiel TJ Tregs and rethinking cancer immunotherapy J Clin Invest 2007, 117:1167-74 1857250 17476346 10.1172/JCI31202
5. Gabrilovich DI Bronte V Chen SH Colombo MP Ochoa A Ostrand-Rosenberg S Schreiber H The terminology issue for myeloid-derived suppressor cells Cancer Res 2007, 67:425 author reply 426 1941787 17210725 10.1158/ 0008-5472.CAN-06-3037
6. Talmadge JE Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy Clin Cancer Res 2007, 13:5243-8 10.1158/ 1078-0432.CCR-07-0182 17875751
7. Serafini P De Santo C Marigo I Cingarlini S Dolcetti L Gallina G Zanovello P Bronte V Derangement of immune responses by myeloid suppressor cells Cancer Immunol Immunother 2004, 53:64-72 10.1007/ s00262-003-0443-2 14593498
8. Sica A Bronte V Altered macrophage differentiation and immune dysfunction in tumor development J Clin Invest 2007, 117:1155-66 1857267 17476345 10.1172/JCI31422
9. Leenen PJ de Bruijn MF Voerman JS Campbell PA van Ewijk W Markers of mouse macrophage development detected by monoclonal antibodies J Immunol Methods 1994, 174:5-19 10.1016/0022-1759(94)90005-1 8083537
10. Gallina G Dolcetti L Serafini P De Santo C Marigo I Colombo MP Basso G Brombacher F Borrello I Zanovello P et al Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells J Clin Invest 2006, 116:2777-90 1578632 17016559 10.1172/JCI28828
11. Yang R Cai Z Zhang Y Yutzy WHt Roby KF Roden RB CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells Cancer Res 2006, 66:6807-15 10.1158/0008-5472.CAN-05-3755 16818658
12. Huang B Pan PY Li Q Sato AI Levy DE Bromberg J Divino CM Chen SH Gr-1+ CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host Cancer Res 2006, 66:1123-31 10.1158/0008-5472.CAN-05-1299 16424049
13. Filipazzi P Valenti R Huber V Pilla L Canese P Iero M Castelli C Mariani L Parmiani G Rivoltini L Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine J Clin Oncol 2007, 25:2546-53 10.1200/JCO.2006.08.5829 17577033
14. Bronte V Zanovello P Regulation of immune responses by L-arginine metabolism Nat Rev Immunol 2005, 5:641-54 10.1038/nri1668 16056256
15. Mazzoni A Bronte V Visintin A Spitzer JH Apolloni E Serafini P Zanovello P Segal DM Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism J Immunol 2002, 168:689-95 11777962
16. Fukumura D Kashiwagi S Jain RK The role of nitric oxide in tumour progression Nat Rev Cancer 2006, 6:521-34 10.1038/nrc1910 16794635
17. Nagaraj S Gupta K Pisarev V Kinarsky L Sherman S Kang L Herber DL Schneck J Gabrilovich DI Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer Nat Med 2007, 13:828-35 2135607 17603493 10.1038/nm1609
18. Muller AJ Scherle PA Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors Nat Rev Cancer 2006, 6:613-25 10.1038/nrc1929 16862192
19. Bronte V Kasic T Gri G Gallana K Borsellino G Marigo I Battistini L Iafrate M Prayer-Galetti T Pagano F et al Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers J Exp Med 2005, 201:1257-68 2213151 15824085 10.1084/jem.20042028
20. Orucevic A Bechberger J Green AM Shapiro RA Billiar TR Lala PK Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness Int J Cancer 1999, 81:889-96 10.1002/ (SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2 10362135
21. Cahlin C Gelin J Delbro D Lonnroth C Doi C Lundholm K Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids Cancer Res 2000, 60:1742-9 10749148
22. Qiu H Orr FW Jensen D Wang HH McIntosh AR Hasinoff BB Nance DM Pylypas S Qi K Song C et al Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells Am J Pathol 2003, 162:403-12 1851169 12547699
23. Serafini P Meckel K Kelso M Noonan K Califano J Koch W Dolcetti L Bronte V Borrello I Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function J Exp Med 2006, 203:2691-702 2118163 17101732 10.1084/jem.20061104
24. Bronte V Serafini P De Santo C Marigo I Tosello V Mazzoni A Segal DM Staib C Lowel M Sutter G et al IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice J Immunol 2003, 170:270-8 12496409
25. Griswold DP Corbett TH A colon tumor model for anticancer agent evaluation Cancer 1975, 36:2441-4 10.1002/ 1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P 1212662
26. Bronte V Apolloni E Cabrelle A Ronca R Serafini P Zamboni P Restifo NP Zanovello P Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells Blood 2000, 96:3838-46 11090068
27. Gordon S Taylor PR Monocyte and macrophage heterogeneity Nat Rev Immunol 2005, 5:953-64 10.1038/nri1733 16322748
28. Kusmartsev S Gabrilovich DI STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion J Immunol 2005, 174:4880-91 15814715
29. Ljunggren HG Karre K Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism J Exp Med 1985, 162:1745-59 2187973 3877776 10.1084/jem.162.6.1745
30. Bissell MJ Radisky D Putting tumours in context Nat Rev Cancer 2001, 1:46-54 10.1038/35094059 11900251
31. Bronte V Serafini P Mazzoni A Segal DM Zanovello P L-arginine metabolism in myeloid cells controls T-lymphocyte functions Trends Immunol 2003, 24:302-6 10.1016/S1471-4906(03)00132-7 12810105
32. Zatz R Baylis C Chronic nitric oxide inhibition model six years on Hypertension 1998, 32:958-64 9856957
33. Baylis C Mitruka B Deng A Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage J Clin Invest 1992, 90:278-81 443093 1634615 10.1172/JCI115849
34. Reisser D Onier-Cherix N Jeannin JF Arginase activity is inhibited by L-NAME, both in vitro and in vivo J Enzyme Inhib Med Chem 2002, 17:267-70 10.1080/1475636021000006252 12530480
35. Martin-Fontecha A Sebastiani S Hopken UE Uguccioni M Lipp M Lanzavecchia A Sallusto F Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming J Exp Med 2003, 198:615-21 2194169 12925677 10.1084/jem.20030448
36. Degl'Innocenti E Grioni M Capuano G Jachetti E Freschi M Bertilaccio MT Hess-Michelini R Doglioni C Bellone M Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells Cancer Res 2008, 68:292-300 10.1158/0008-5472.CAN-07-2429 18172322
37. Iezzi G Protti MP Rugarli C Bellone M B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines Cancer Res 1996, 56:11-5 8548749
38. Iezzi G Rivolta L Ronchetti A Martin-Fontecha A Rosato A Protti MP Sabbadini MG Bellone M The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes Cancer Res 1997, 57:2564-8 9205054
39. Kusmartsev S Cheng F Yu B Nefedova Y Sotomayor E Lush R Gabrilovich D All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination Cancer Res 2003, 63:4441-9 12907617
40. De Santo C Serafini P Marigo I Dolcetti L Bolla M Del Soldato P Melani C Guiducci C Colombo MP Iezzi M et al Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination Proc Natl Acad Sci USA 2005, 102:4185-90 554823 15753302 10.1073/pnas.0409783102
41. Gorer PA Studies in antibody response of mice to tumour inoculation Br J Cancer 1950, 4:372-9 14801344
42. Bertilaccio MT Grioni M Sutherland BW Degl'Innocenti E Freschi M Jachetti E Greenberg NM Corti A Bellone M Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer Prostate 2008, 68:1105-15 10.1002/pros.20775 18437689
43. Camporeale A Boni A Iezzi G Degl'Innocenti E Grioni M Mondino A Bellone M Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes Cancer Res 2003, 63:3688-94 12839960